Boyi
Latest round
- Series A
Last raised
- Aug 2024
Total raised
- $14M
Investors
- 4
About Boyi
Based in Changzhou, China, and founded in 2022, Boyi is a biotech company providing in vitro diagnostic material for biomedical customers. The company's business can be categorized into diagnostic microspheres, assay raw materials, customized services, and large package reagents, which include latex microspheres, colored microspheres, fluorescent microspheres, antigens, antibodies, enzymes, and other raw materials for IVD assays. The company’s revenue is generated by providing in vitro diagnostic core raw materials.
Who invested in Boyi
4 investors across 2 rounds
See all investors in Boyi
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Boyi
Who invested in Boyi?
Boyi has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Boyi raised?
Boyi has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Boyi last raise money?
Boyi's most recent round on record is a Series A, in Aug 2024.
What does Boyi do?
Based in Changzhou, China, and founded in 2022, Boyi is a biotech company providing in vitro diagnostic material for biomedical customers.
Where is Boyi headquartered?
Boyi is headquartered in Changzhou, China.
Which VCs invest in companies like Boyi?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Boyi's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Boyi? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.